{"schema_version":"1","generated_at":"2026-11-05T08:02:11.054Z","data_as_of":null,"url":"https://www.findmykol.com/kol/tamanna-haque","json_url":"https://www.findmykol.com/kol/tamanna-haque/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"tamanna-haque","name":"Tamanna Haque","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Memorial Sloan Kettering Cancer Center","institution_url":"https://www.findmykol.com/institution/memorial-sloan-kettering-cancer-center","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1285035402","orcid":"0009-0001-7999-5842","openalex":"A5085150089"},"summary":"Tamanna Haque is an Oncology physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 45 publications with 337 citations (h-index 10).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":45,"cited_by_count":337,"h_index":10,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":13,"shown":3,"withheld":10,"rows":[{"payer":"Sumitomo Pharma","program_year":2025,"amount_usd":198083.98,"payment_count":198,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285035402"},{"payer":"Novartis","program_year":2025,"amount_usd":89624.31,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285035402"},{"payer":"Agios","program_year":2025,"amount_usd":14910,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285035402"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1285035402","source":"payments"},"publications":{"total":45,"shown":5,"withheld":40,"matched_by":"OpenAlex author record","recent":[{"title":"NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025","year":2025,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2025.0013","status":"verified"},{"title":"Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025018178","status":"verified"},{"title":"Preliminary data from the Phase I/II study of nuvisertib, an oral investigational selective PIM1 inhibitor, in combination with momelotinib showed clinical responses in patients with relapsed/refractory myelofibrosis","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-482","status":"verified"},{"title":"Nuvisertib, an oral investigational selective PIM1 kinase inhibitor, showed clinical responses strongly correlating with cytokine modulation in patients with relapsed/refractory myelofibrosis in the ongoing global phase I/II study","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-2018","status":"verified"},{"title":"The outcomes of patients who are relapsed or refractory to menin inhibitors is poor with a limited overall survival","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-39","status":"verified"}],"source":"works"},"contact":{"address_1":"530 E 74TH ST","city":"New York","state":"NY","zip":"100213459","phone":"646-608-4166","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1285035402","source":"identity"},"similar":[{"name":"Howard Scher","slug":"howard-scher","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/howard-scher","json_url":"https://www.findmykol.com/kol/howard-scher/profile.json"},{"name":"Robert Motzer","slug":"robert-motzer","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/robert-motzer","json_url":"https://www.findmykol.com/kol/robert-motzer/profile.json"},{"name":"Charles Sawyers","slug":"charles-sawyers","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/charles-sawyers","json_url":"https://www.findmykol.com/kol/charles-sawyers/profile.json"},{"name":"Mark Kris","slug":"mark-kris","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/mark-kris","json_url":"https://www.findmykol.com/kol/mark-kris/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":10,"publications":40}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-03-17","provider_certified":"2025-03-17","collected_at":"2026-11-04T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}